Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England von Flaum, Nicola, Morgan, Robert D, Burghel, George J, Bulman, Michael, Clamp, Andrew R, Hasan, Jurjees, Mitchell, Claire L, Badea, Doina, Moon, Sarah, Hogg, Martin, Hadjiyiannakis, Dennis, Clancy, Tara, Schlecht, Helene, Woodward, Emma R, Crosbie, Emma J, Edmondson, Richard J, Wallace, Andrew J, Jayson, Gordon C, Lalloo, Fiona I, Harkness, Elaine F, Evans, D Gareth R

Volltext

High-grade serous ovarian cancer after bilateral salpingo-oophorectomy von Evans, D Gareth, Flaum, Nicola, Crosbie, Emma J

Volltext

Epithelial ovarian cancer risk: A review of the current genetic landscape von Flaum, Nicola, Crosbie, Emma J., Edmondson, Richard J., Smith, Miriam J., Evans, Dafydd G.

Volltext

Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis von Flaum, Nicola, Hubner, Richard, Valle, Juan, Amir, Eitan, Mcnamara, Mairead

Volltext

Optimization of polygenic risk scores in BRCA1/2 pathogenic variant heterozygotes in epithelial ovarian cancer von Flaum, Nicola, Bowes, John, Smith, Miriam J., Crosbie, Emma J., Edmondson, Richard, Lophatananon, Artitaya, Evans, D. Gareth

Volltext

Cross-cultural adaptation of the PROFFIT Instrument to measure financial toxicity in people living with cancer within a UK population von Patel, Alkesh, Perrone, Francesco, Ashcroft, Darren M., Flaum, Nicola, Cook, Natalie, Riva, Silvia

Volltext

High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer von Flaum, Nicola, Crosbie, Emma J., Edmondson, Richard, Woodward, Emma R., Lalloo, Fiona, Smith, Miriam J., Schlecht, Helene, Evans, D. Gareth

Volltext

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low l... von Crosbie, Emma J., Flaum, Nicola, Harkness, Elaine F., Clayton, Richard D., Holland, Cathrine, Martin‐Hirsch, Pierre, Wood, Nick, Keating, Patrick, Woodward, Emma R., Lalloo, Fiona, Donnai, Paul, Edmondson, Richard J., Evans, D. Gareth

Volltext

Balancing the Economics and Ethics of Personalised Oncology von Flaum, Nicola, Hall, Peter, McCabe, Christopher

Volltext

Dominant‐negative pathogenic variant BRIP1 c. 1045G >C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study von Flaum, Nicola, van Veen, Elke M., Smith, Olivia, Amico, Stephanie, Newman, William G., Crosbie, Emma J., Edmondson, Richard, Smith, Miriam J., Evans, D. Gareth

Volltext

Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants von Flaum, Nicola, Crosbie, Emma J., Woodward, Emma R., Lalloo, Fiona, Gareth Evans, D.

Volltext

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer von Morgan, Robert D, Burghel, George J, Flaum, Nicola, Bulman, Michael, Smith, Philip, Clamp, Andrew R, Hasan, Jurjees, Mitchell, Claire, Salih, Zena, Woodward, Emma R, Lalloo, Fiona, Shaw, Joseph, Desai, Sudha, Crosbie, Emma J, Edmondson, Richard J, Schlecht, Helene, Wallace, Andrew J, Jayson, Gordon C, Evans, D. Gareth R

Volltext

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene von Morgan, Robert D., Burghel, George J., Flaum, Nicola, Schlecht, Helene, Clamp, Andrew R., Hasan, Jurjees, Mitchell, Claire, Salih, Zena, Moon, Sarah, Hogg, Martin, Lord, Rosemary, Forde, Claire, Lalloo, Fiona, Woodward, Emma R., Crosbie, Emma J., Taylor, Stephen S., Jayson, Gordon C., Evans, D. Gareth R.

Volltext

Adjuvant chemotherapy and outcomes in patients with nodal and resection margin‐negative pancreatic ductal adenocarcinoma: A systematic review and meta‐analysis von Flaum, Nicola, Hubner, Richard A., Valle, Juan W., Amir, Eitan, McNamara, Mairéad G.

Volltext

Adjuvant chemotherapy and outcome in patients (pts) with nodal (N-) and resection margin negative (R0) pancreatic adenocarcinoma (PC): A systematic review and meta-analysis von Flaum, Nicola, Hubner, Richard, Valle, Juan W., Amir, Eitan, McNamara, Mairead G

Volltext

BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing? von Morgan, Robert D., Burghel, George J., Flaum, Nicola, Bulman, Michael, Smith, Philip, Clamp, Andrew R., Hasan, Jurjees, Mitchell, Claire L., Salih, Zena, Woodward, Emma R., Lalloo, Fiona, Crosbie, Emma J., Edmondson, Richard J., Wallace, Andrew J., Jayson, Gordon C., Evans, D. Gareth R.

Volltext

Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer von Morgan, Robert D, Burghel, George J, Flaum, Nicola, Bulman, Michael, Smith, Philip, Clamp, Andrew R, Hasan, Jurjees, Mitchell, Claire, Salih, Zena, Woodward, Emma R, Lalloo, Fiona, Shaw, Joseph, Desai, Sudha, Crosbie, Emma J, Edmondson, Richard J, Schlecht, Helene, Wallace, Andrew J, Jayson, Gordon C, Evans, D Gareth R

Volltext

Dominant‐negative pathogenic variant BRIP1 c.1045G>C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study von Flaum, Nicola, Veen, Elke M., Smith, Olivia, Amico, Stephanie, Newman, William G., Crosbie, Emma J., Edmondson, Richard, Smith, Miriam J., Evans, D. Gareth

Volltext

Everolimus in the treatment of neuroendocrine tumors of the respiratory and gastroenteropancreatic systems von Flaum , Nicola, Valle, Juan, Mansoor, Wasat, Mcnamara, Mairead

Volltext

Financial burden and financial toxicity in patients with colorectal, gastro-oesophageal, and pancreatobiliary cancers: A UK study von Flaum, Nicola, Papaxoinis, George, Hockenhull, Kimberley, Barrusio, Jorge, Backen, Alison, Cunningham, David, Mansoor, Wasat

Volltext